Evidence map›Paper›PMID 26862387›Full record

ArticleJundishapur journal of microbiology2015

Production of IFN-γ and IL-4 Against Intact Catalase and Constructed Catalase Epitopes of Helicobacter pylori From T-Cells.

Hajieh Ghasemian Safaei, Jamshid Faghri, Sharareh Moghim, Bahram Nasr Esfahani, Hossein Fazeli, Manoochehr Makvandi, Minoo Adib, Niloufar Rashidi

Open access · hybridAbstract read
In one paragraph

Article in Jundishapur journal of microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Targeting catalase in cancer.Redox biology · 2024
    Review
  3. Article
  4. Molecular Assessment of Resistance to Clarithromycin inBioMed research international · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hajieh Ghasemian SafaeiDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Jamshid FaghriDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Sharareh MoghimDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Bahram Nasr EsfahaniDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Hossein FazeliDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Manoochehr MakvandiDepartment of Virology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran.
Minoo AdibDepartment of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Niloufar RashidiDepartment of Laboratory Sciences, Paramedical School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran; Research Institute for Infectious Disease of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran.
Isfahan University of Medical Sciences · IRAhvaz Jundishapur University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHelicobacter pylori infection is highly prevalent in the developing countries. It causes gastritis, peptic ulcer disease, and gastrocarcinoma. Treatment with drugs and antibiotics is problematic due to the following reasons: cost, resistance to antibiotics, prolonged treatment and using multiple drugs. Catalase is highly conserved among the Helicobacter species and is important to the survival of the organism. It is expressed in high amounts and is exposed to the surface of this bacterium; therefore it represents a suitable candidate vaccine antigen.

objectivesA suitable approach in H. pylori vaccinology is the administration of epitope based vaccines. Therefore the responses of T-cells (IFN-γ and IL-4 production) against the catalase of H. pylori were determined. Then the quality of the immune responses against intact catalase and three epitopes of catalase were compared. MATERIALS AND

methodsIn this study, a composition of three epitopes of the H. pylori catalase was selected based on Propred software. The effect of catalase epitopes on T-cells were assayed and immune responses identified.

resultsThe results of IFN-γ, IL-4 production against antigens, epitopes, and recombinant catalase by T-cells were compared for better understanding of epitope efficiency.

conclusionsThe current research demonstrated that epitope sequence stimulates cellular immune responses effectively. In addition, increased safety and potency as well as a reduction in time and cost were advantages of this method. Authors are going to use this sequence as a suitable vaccine candidate for further research on animal models and humans in future.

Indexed as

CatalaseEpitopesHelicobacter pyloriImmune ResponsesT-Cell

Identifiers

PMID26862387
PMCPMC4741185
OpenAlexW2191039745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.